KREITZER ANATOL (Chief Discovery Officer) reported 1 transaction at MAPLIGHT THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/29/2026ACC: 0002021238-26-000002
Officer· Chief Discovery Officer
Since Feb 2026
-42.10K
Net shares
Net seller
$756.9K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
42.10K disposed
Non-Derivative Transactions1
Voting Common Stock
Direct
Shares
−42.10K
Price / share
$17.98
Trade value
$756.94K
% of position
14.2%
1/27/2026
296.01K→253.91K
Total
Net shares
−42.10K
Net value
-$756.94K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Voting Common Stock Direct | 1/27/2026 | F · Tax Withholding | −42.10K | $17.98 | $756.94K | 14.2% | 296.01K | 253.91K |
| Total | −42.10K | -$756.94K | ||||||
Derivative Transactions0
No derivative transactions reported